Melatonin as a pathway to decrease mortality rates associated with antipsychotic therapy. VI SIMPOSIO DE PSICOSOMÁTICA Y PSIQUIATRÍA, Barcelona 2023

Main Article Content

Dmytro Krupka
Ricardo Jorge Correia
Pedro Aresta
Francisca Aires
Joaquim José Sá Couto
Beatriz Araujo
Joana Rodrigues
Alexandre Mendes
Paraules clau
Side effects of long-term treatment with atypical antipsychotic drugs, Melatonin to counteract metabolic side effects

Article Details

Com citar
Krupka, Dmytro et al. “Melatonin as a pathway to decrease mortality rates associated with antipsychotic therapy.: VI SIMPOSIO DE PSICOSOMÁTICA Y PSIQUIATRÍA, Barcelona 2023”. Psicosomàtica y Psiquiatría, no. 27, doi:10.60940/PsicosomPsiquiatrnum270918.